VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) — Rio2 Limited (“Rio2” or the “Company”) (TSXV: RIO; OTCQX: RIOFF; BVL: RIO) announces the results of voting at its Annual and Special General Meeting of Shareholders (the “Meeting”) held June 4, 2025. A total of 238,282,608 common shares were voted, representing 55.82% of 426,846,684 shares issued and outstanding as of the record date of the Meeting. Shareholders voted in favour of all items of business before the Meeting, including the election of all director nominees as follows:  VOTES FOR % VOTES FOR VOTESWITHHELD % VOTESWITHHELDKlaus Zeitler 202,502,363 98.43% 3,220,900 1.57%Alex Black 205,702,663 99.99% 20,600 0.01%Andrew Cox 205,701,839 99.99% 21,424 0.01%Ram Ramachandran 205,720,439 100.00% 2,824 0.00%Albrecht Schneider 205,701,939 99.99% 21,324 0.01%Sidney...

Low-Cost Domestic Titanium for Defense Applications: Receipt of an SBIR Phase III Indefinite Delivery, Indefinite Quantity (IDIQ) contract to achieve “Low-Cost Domestic Titanium for Defense Applications” in the U.S. SBIR phase III contract: Enables IperionX to receive task order funding from U.S. Department of Defense (DoD) agencies up to a total of US$99 million Accelerating commercial deployment: SBIR Phase III contracts are reserved for technologies ready to transition from R&D into scaled production for U.S. Government use Strategic initial projects: Initial task orders will focus on manufacturing high-performance titanium fasteners for U.S. DoD agenciesCHARLOTTE, N.C., June 05, 2025 (GLOBE NEWSWIRE) — IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) is pleased to announce that is has been awarded a Small Business...

HINGHAM, Mass., June 05, 2025 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, announced that it has been selected for inclusion in the preliminary list of additions to the Russell Microcap® Index, as published by FTSE Russell on Friday, May 23, 2025. The newly reconstituted indexes are expected to take effect after U.S. market close on Friday, June 27, 2025, and be part of the 2025 Russell indexes reconstitution when the U.S. market opens on Monday, June 30, 2025. The annual Russell US Indexes reconstitution captures the 4,000 largest US stocks as of Wednesday, April 30, 2025, ranking them by total market capitalization. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and...

Scottsdale, AZ, June 05, 2025 (GLOBE NEWSWIRE) — CISO Global Inc. (NASDAQ: CISO), an industry leader in AI-powered security software, managed cybersecurity services, and compliance solutions, today announced its successful completion of its SOC 2 Type II examination. The audit, which reviewed a 12-month period, was conducted by A-LIGN—a trusted cybersecurity compliance firm serving over 4,000 organizations worldwide. The successful audit validates that CISO Global’s data privacy practices and security controls meet the highest standards in the industry. “We are incredibly proud to have successfully completed our SOC 2 audit for the third year in a row,” said CEO, David Jemmett. “This is an achievement that reflects our unwavering commitment to security, trust, and operational excellence. The work from our compliance team...

VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) — Pulse Oil Corp. (“Pulse” or the “Company”) (TSXV: PUL) is pleased to announce that Pulse has entered into two loan Facility Agreements (the “Facility Agreements”) with related parties to the Company (the “Lenders”), whereby the Lenders have agreed to loan to the Company (collectively, the “Loans”), in aggregate, the sum of $2,250,000 (the “Principal”). Pursuant to the Facility Agreements, the Loans will be made available in tranches of $1,125,000 primarily to fund the Bigoray EOR project’s solvent injection program. The Facility Agreements provide that the principal bears interest at the rate of 15% per annum (the “Interest Rate”), compounded monthly, with fixed partial interest payments being made on a quarterly basis starting on September 30, 2025 in the amount...

NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) — via InvestorWire — ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 70+ brands within the Dynamic Brand Portfolio @IBN , a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view the full publication, “Wall Street Targets Breakout Gold Producers as Bull Market Accelerates,” please visit: https://IBN.fm/RtMP5 With gold soaring past $3,000 per ounce in May 2025 — outperforming NASDAQ, the S&P 500, and even bitcoin — Wall Street’s attention is shifting. As U.S. debt-to-GDP climbs above 120% and real interest rates remain negative, gold continues to prove itself as the market’s most dependable...

SAN DIEGO, June 05, 2025 (GLOBE NEWSWIRE) — Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced the pricing of its previously announced public offering of 15,714,285 shares of its Class A Common Stock, at a purchase price of $1.75 per share, including to institutional and strategic investors, as well as the Chairman of Cibus’ board of directors (5,714,286 shares). All of the shares of Class A Common Stock in the offering will be sold by Cibus. The gross proceeds of the offering are expected to be approximately $27.5 million before deducting placement agent fees and other estimated offering expenses payable by the Company. The offering is expected...

HealthOST identifies vertebral height loss and bone mineral density, which are key indicators of musculoskeletal disease Osteoporosis is a common progressive bone disease among adults over 50 years of age that causes bones to weaken, leading to fractures The software provides automated quantification of vertebral parameters from routine CT scans, delivering consistent and objective data to support physician evaluation, before life-altering fractures occurPETACH TIKVA, Israel, June 05, 2025 (GLOBE NEWSWIRE) — NANO-X IMAGING LTD (“Nanox” or the “Company”, Nasdaq: NNOX), an innovative medical imaging technology company, today announced that its deep-learning medical imaging analytics subsidiary, Nanox AI Ltd, has received EU MDR CE (Conformité Européenne) mark certification for HealthOST, an SaMD (Software...

Landmark Peer-Reviewed Study Demonstrates Effectiveness of Personalized Dietary Therapy for IBS Patients Using inFoods® IBS Test. Gastroenterology, the premier journal in gastrointestinal science, features data supporting inFoods IBS as an effective personalized, non-drug approach for managing IBS. Study results suggest inFoods IBS could be particularly beneficial for IBS-M patients, a population with no current FDA-approved drug treatments.IRVINE, Calif., June 05, 2025 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA), a global leader in advanced diagnostic-guided therapies, today announced that data from its pivotal clinical trial evaluating the inFoods® IBS test in treating IBS sufferers has been published in the June 2025 issue of Gastroenterology, the official journal of the American Gastroenterological Association and...